Lumexa Imaging reiterates 2026 guidance

Lumexa Imaging Holdings, Inc. reported that on April 8, 2026 it held a meeting and site visit where it reiterated its previously disclosed full year 2026 guidance.

Rhea-AI Filing Summary

Lumexa Imaging Holdings, Inc. reported that on April 8, 2026 it held a meeting and site visit where it reiterated its previously disclosed full year 2026 guidance. The company stated this information is furnished under Item 7.01 and is not deemed filed under Section 18 of the Exchange Act unless specifically designated or incorporated by reference.

8-K Event Classification

Item 7.01 — Regulation FD Disclosure

1 item

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Key Terms

full year 2026 guidance, Item 7.01, Section 18 of the Securities Exchange Act of 1934, Emerging growth company

4 terms

full year 2026 guidance financial

"the Company reiterated its previously disclosed full year 2026 guidance"

Item 7.01 regulatory

"The information furnished pursuant to Item 7.01 of this report"

Item 7.01 is the Regulation FD Disclosure entry on the SEC Form 8‑K, used when a public company has made material nonpublic information public and needs to report how that disclosure was handled (for example by furnishing a press release, presentation, or webcast). It tells investors that important information was released to the market and where to find the disclosure, helping ensure everyone had equal access to news that could affect the company’s stock price, like broadcasting a press briefing so no one gets a private scoop.

Section 18 of the Securities Exchange Act of 1934 regulatory

"shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934"

Emerging growth company regulatory

"Emerging growth company    On April 8, 2026, Lumexa Imaging Holdings, Inc."

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Lumexa Imaging Holdings (LMRI) announce on April 8, 2026?

Lumexa Imaging Holdings held a meeting and site visit on April 8, 2026 where it reiterated its previously disclosed full year 2026 guidance. No new financial figures were introduced, only a confirmation of the existing outlook already communicated earlier.

Did Lumexa Imaging (LMRI) change its full year 2026 guidance in this update?

No, Lumexa Imaging reiterated its previously disclosed full year 2026 guidance. The company simply restated the same outlook during a meeting and site visit on April 8, 2026, rather than providing revised or updated financial projections for the year.

Under which SEC item was Lumexa Imaging’s guidance reiteration furnished?

The guidance reiteration was furnished under Item 7.01, which covers Regulation FD disclosure. Information provided under this item is supplied for transparency and is generally treated differently from information that is formally filed under other Exchange Act sections.

Is Lumexa Imaging’s April 8, 2026 guidance reiteration considered filed under Section 18?

The company stated that the information furnished under Item 7.01 is not deemed filed under Section 18 of the Exchange Act, or subject to that section’s liabilities, unless Lumexa specifically designates it as filed or incorporates it by reference into another filing.

What is the significance of Lumexa Imaging furnishing rather than filing this information?

By furnishing the guidance reiteration under Item 7.01, Lumexa limits how it is treated under the Exchange Act. Furnished information is not automatically subject to Section 18 liabilities, unless the company later chooses to treat it as filed or incorporate it into another registration or report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/09/2026 - 05:11 PM EDT Learn about SEC filing dates

false 0002071288 0002071288 2026-04-08 2026-04-08

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): April 8, 2026

Lumexa Imaging Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware		001-43010		41-2605845
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

4200 Six Forks Road
Suite 1000
Raleigh, North Carolina		27609
(Address of Principal Executive Offices)		(Zip Code)

(919) 763-1100

(Registrant’s telephone number, including area code)

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
Common Stock, $0.001 par value per share		LMRI		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure.

On April 8, 2026, Lumexa Imaging Holdings, Inc. (the “Company”) held a meeting and site visit where the Company reiterated its previously disclosed full year 2026 guidance.

The information furnished pursuant to Item 7.01 of this report shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered “filed” under the Exchange Act or incorporates it by reference into a filing under the Securities Act of 1933 or the Exchange Act.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				LUMEXA IMAGING HOLDINGS, INC.
				By:		/s/ J. Anthony Martin
Date: April 9, 2026				Name:		J. Anthony Martin
				Title:		Chief Financial Officer

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 2.8 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 18.3 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 11.4 KB